Coverage And Compliance Of Mass Drug Administration For Elimination Of Lymphatic Filariasis In Endemic Areas Of Bagalkot District, Karnataka

Evaluation of MDA coverage in Bagalkot District

Authors

  • M.M. Angadi
  • Shashank K J
  • Rohith M

DOI:

https://doi.org/10.70284/njirm.v6i2.880

Keywords:

Mass Drug Administration, Filariasis, Compliance,Diethyl carbamazine, Coverage, Coverage

Abstract

Backround:Mass d-rug administration (MDA), for control of filariasis was launched by government of India in 1996. Under this programme, all the beneficiaries in the age group of 2 to 60 years (excluding pregnant mothers, people above 60 and having other illness), will be administered. Filariasis being endemic in the District Methodology: The MDA was carried out in the district in the month of May 2014. This study was conducted To assess the coverage and compliance of MDA in Bagalkot district in the year 2014. After visiting the selected cluster ( 3 rural and 1 urban) the information was collected from the 30 houses in each cluster randomly.Results : Out of 720 population surveyed 353 (49.02%) were males and 367 (50.98%) were female ,3.1% of geriatric population were given the drugs . 406 (56.4%) had taken full course, 58 (8.1%) had partially taken the drugs while 256 (35.5%) had either not received the drugs or had not taken the tablet. Though the coverage was high, the compliance was only 56.4 %, which is much below the target of 85%. Main reason for noncompliance was lack of adequate information .Conclusion :Effective drug delivery strategies such as proper area demarcation, repeat house visits have to be done to improve coverage. Training of drug distributors to improve interpersonal communication & effective IEC activities are to be emphasized to improve compliance & achieve elimination of filariasis.[Angadi M. NJIRM 2015; 6(2): 50-53]

References

1. Park K.. Textbook of preventive and Social Medicine. 22nd edition. Bhannot Publication, Jabalpur. India.
2. Lessons from the Pacific programme to eliminate lymphatic filariasis: a case study of 5 countries.[Internet].2014[cited 2014 Dec 12]. Available from URL:http://www.biomedcentral.com/content/pdf/1471-2334-9-92.pdf
3. Filariasis. World Health Organization..[Internet].2014[updated 2014 Dec 15; cited 2014 Dec 12].Avialable from http://www.who.int/topics/filariasis/en/.
4. National Vector Borne Disease Control Programme. Directorate General of Health Services. Ministry Of Health and Family welfare. India..[Internet].2014[cited 2014 Dec 12]. Available fromhttp://nvbdcp.gov.in/filariasis-new.html.
5. Filariasis Control in India & Its Elimination. National Vector Borne Disease Control Programme.[Internet].2014[cited 2014 Dec 17]. Avilable from http://nvbdcp.gov.in/doc/guidelines-filariasis-elimination-india.pdf.
6. Patel P R. Mass Drug Administration Coverage Evaluation Survey for Lymphatic Filariasis in Bagalkot and Gulbarga Districts. Indian Journal of Community Medicine.2010;37(2):101-106.
7. Ravish K S, Ranganath T S ,RiyazBasha S. Coverage And Compliance Of Mass Drug Administration For Elimination Of Lymphatic Filariasis In Endemic Areas Of Bijapur District, Karnataka. International Journal of Basic Medical Science.2011;2(2):88-89.
8. Muralidhar M K et al . Coverage & Compliance of Mass Drug Administration Program
againstFilariasis in Bijapur District, Karnataka.J Pub Health Med Res 2013;1(1):9-12..
9. Mallayya D et al . Coverage and compliance MDA programme for lymphatic filariasis in Bidar district, Karnataka, India. Asian Pac J Trop Dis 2012; 2(4): 290-292.

Downloads

Published

2018-01-09

How to Cite

Angadi, M., K J, S., & M, R. (2018). Coverage And Compliance Of Mass Drug Administration For Elimination Of Lymphatic Filariasis In Endemic Areas Of Bagalkot District, Karnataka: Evaluation of MDA coverage in Bagalkot District. National Journal of Integrated Research in Medicine, 6(2), 51–54. https://doi.org/10.70284/njirm.v6i2.880

Issue

Section

Original Articles